cladribine prodrug (Nucana)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namecladribine prodrug (Nucana)
Drug Alias NameNUC-6285
ClassificationSmall molecules > Nucleosides and nucleotide derivtives
Mechanisms of ActionAdenosine deaminase inhibitors
TargetsAdenosine deaminase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNucana Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNucana Plc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A